Calithera Biosciences, Inc
CALA
CALA was delisted on the 1st of February, 2023.
55 hedge funds and large institutions have $27M invested in Calithera Biosciences, Inc in 2021 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 19 increasing their positions, 16 reducing their positions, and 19 closing their positions.
329% more call options, than puts
Call options by funds: $236K | Put options by funds: $55K
19% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 16
17% less funds holding
Funds holding: 66 → 55 (-11)
47% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 19
73% less capital invested
Capital invested by funds: $100M → $27M (-$73.1M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$3.1M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$2.14M |
| 3 |
D.E. Shaw & Co
New York
|
+$1.84M |
| 4 |
Two Sigma Advisers
New York
|
+$1.4M |
| 5 |
Renaissance Technologies
New York
|
+$1.23M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$8.38M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
-$4.69M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.66M |
| 4 |
BlackRock
New York
|
-$776K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$678K |
CALA Hedge Fund Activity: Q4 2021 in Review
55 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Calithera Biosciences, Inc (CALA) for Q4 2021, worth a combined $27M — down 73% from $100M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of CALA and 10 opened new positions — a net loss of 9 holders — while 16 trimmed existing stakes and 19 added.
The largest buyer was Citadel Advisors, adding an estimated $3.1M. The largest seller was Federated Hermes, cutting an estimated $8.38M.
- 55 institutional investors held Calithera Biosciences, Inc (CALA) as of Q4 2021, down from 66 in Q3 2021.
- Funds reported $27M of Calithera Biosciences, Inc stock for Q4 2021, down 73% quarter-over-quarter.
- 10 funds opened new Calithera Biosciences, Inc positions in Q4 2021 and 19 closed out, a net change of -9 holders.
- The largest Calithera Biosciences, Inc buyer in Q4 2021 was Citadel Advisors, an estimated $3.1M added.
- The largest Calithera Biosciences, Inc seller in Q4 2021 was Federated Hermes, an estimated $8.38M sold.
Based on aggregated 13F filings for Q4 2021.